T790M Mutation Positive 2nd Line STandard of cAre Registry

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

June 30, 2015

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2018

Conditions
Non Small Cell Lung Cancer
Trial Locations (49)

Unknown

Research Site, Kentucky

Research Site, Maryland City

Research Site, Langhorne

Research Site, Beijing

Research Site, Changsha

Research Site, Guangzhou

Research Site, Jiangsu

Research Site, Jilin

Research Site, Shanghai

Research Site, Shanghai Ruijin Hospital

Research Site, Sichuan Cancer Hospital

Research Site, Xi'an

Research Site, Boulogne-Billancourt

Research Site, Bretagne

Research Site, La Chaussée-Saint-Victor

Research Site, Lille

Research Site, Pontoise

Research Site, Rhone-Alpes

Research Site, Saint-Quentin

Research Site, Esslingen am Neckar

Research Site, Catania

Research Site, Ferrara

Research Site, Messina

Research Site, Modena

Research Site, Napoli

Research Site, Padua

Research Site, Parma

Research Site, Perugia

Research Site, Rome

Research Site, Torino

Research Site, Groningen

Research Site, Barnaul

Research Site, Saint Petersburg

Research Site, A Coruña

Research Site, Alicante

Research Site, Badalona

Research Site, Barcelona

Research Site, León

Research Site, Lugo

Research Site, Madrid

Research Site, Ourense

Research Site, Pamplona

Research Site, Santander

Research Site, Seville

Research Site, Valencia

Research Site, Vizcaya

Research Site, Linkou District

Research Site, Taichung

Research Site, Taipei

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Parexel

INDUSTRY

lead

AstraZeneca

INDUSTRY